83 related articles for article (PubMed ID: 8894515)
1. Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
Yuan JH; Birkmeier J; Yang DC; Hribar JD; Liu N; Bible R; Hajdu E; Rock M; Schoenhard G
Drug Metab Dispos; 1996 Oct; 24(10):1124-33. PubMed ID: 8894515
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
Kachur JF; Askonas LJ; Villani-Price D; Ghoreishi-Haack N; Won-Kim S; Liang CD; Russell MA; Smith WG
J Pharmacol Exp Ther; 2002 Feb; 300(2):583-7. PubMed ID: 11805220
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.
Askonas LJ; Kachur JF; Villani-Price D; Liang CD; Russell MA; Smith WG
J Pharmacol Exp Ther; 2002 Feb; 300(2):577-82. PubMed ID: 11805219
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.
Penning TD; Russell MA; Chen BB; Chen HY; Liang CD; Mahoney MW; Malecha JW; Miyashiro JM; Yu SS; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
J Med Chem; 2002 Aug; 45(16):3482-90. PubMed ID: 12139459
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.
Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Liang CD; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
Bioorg Med Chem Lett; 2002 Dec; 12(23):3383-6. PubMed ID: 12419366
[TBL] [Abstract][Full Text] [Related]
6. QSAR, docking studies and pharmacophore identification of phenylmethyl phenoxy propyl amino propanoic acid derivatives as leukotriene A4 hydrolase inhibitors.
Sonawane LV; Bari SB
Yao Xue Xue Bao; 2010 May; 45(5):615-23. PubMed ID: 20931764
[TBL] [Abstract][Full Text] [Related]
7. Amalgamation of stress degradation and metabolite profiling in rat urine and feces for characterization of oxidative metabolites of flibanserin using UHPLC-Q-TOF-MS/MS, H/D exchange and NMR technique.
Sharma MK; Shah RP; Sengupta P
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1139():121993. PubMed ID: 32004940
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors.
Liu JY; Tsai HJ; Morisseau C; Lango J; Hwang SH; Watanabe T; Kim IH; Hammock BD
Biochem Pharmacol; 2015 Dec; 98(4):718-31. PubMed ID: 26494425
[TBL] [Abstract][Full Text] [Related]
9. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene A4 hydrolase in the human lung. Inactivation of the enzyme with leukotriene A4 isomers.
Ohishi N; Izumi T; Minami M; Kitamura S; Seyama Y; Ohkawa S; Terao S; Yotsumoto H; Takaku F; Shimizu T
J Biol Chem; 1987 Jul; 262(21):10200-5. PubMed ID: 3038871
[TBL] [Abstract][Full Text] [Related]
11. Testicular distribution and toxicity of a novel LTA4H inhibitor in rats.
Ward PD; La D
Toxicol Appl Pharmacol; 2014 Jul; 278(1):26-30. PubMed ID: 24769091
[TBL] [Abstract][Full Text] [Related]
12. Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urine.
Blanz J; Délémonté T; Pearson D; Luneau A; Ritzau M; Gertsch W; Ramstein P; Dayer J; Desrayaud S; Braun E; Aichholz R
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():1-10. PubMed ID: 25797717
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel ondansetron metabolites using LC/MS
Duan M; Qin L; Zhong D; Zhang P
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1095():138-141. PubMed ID: 30077093
[TBL] [Abstract][Full Text] [Related]
14. Formation of conjugates of 2-fluoro-beta-alanine and bile acids during the metabolism of 5-fluorouracil and 5-fluoro-2-deoxyuridine in the isolated perfused rat liver.
Sweeny DJ; Barnes S; Diasio RB
Cancer Res; 1988 Apr; 48(8):2010-4. PubMed ID: 2964897
[TBL] [Abstract][Full Text] [Related]
15. Zinc and other divalent cations inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
Wetterholm A; Macchia L; Haeggström JZ
Arch Biochem Biophys; 1994 Jun; 311(2):263-71. PubMed ID: 8203889
[TBL] [Abstract][Full Text] [Related]
16. Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Grice CA; Tays KL; Savall BM; Wei J; Butler CR; Axe FU; Bembenek SD; Fourie AM; Dunford PJ; Lundeen K; Coles F; Xue X; Riley JP; Williams KN; Karlsson L; Edwards JP
J Med Chem; 2008 Jul; 51(14):4150-69. PubMed ID: 18588282
[TBL] [Abstract][Full Text] [Related]
17. Regiospecific and stereospecific triangulation of the structures of metabolites formed by sequential metabolism at multiple prochiral centers.
Greene RJ; Davis JA; Subramanian R; Deane MR; Emery MG; Slatter JG
Drug Metab Dispos; 2012 May; 40(5):928-42. PubMed ID: 22328582
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.
Khim SK; Bauman J; Evans J; Freeman B; King B; Kirkland T; Kochanny M; Lentz D; Liang A; Mendoza L; Phillips G; Tseng JL; Wei RG; Ye H; Yu L; Parkinson J; Guilford WJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):3895-8. PubMed ID: 18590959
[TBL] [Abstract][Full Text] [Related]
19. Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometry.
Luffer-Atlas D; Vincent SH; Painter SK; Arison BH; Stearns RA; Chiu SH
Drug Metab Dispos; 1997 Aug; 25(8):940-52. PubMed ID: 9280402
[TBL] [Abstract][Full Text] [Related]
20. Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.
Eldrup AB; Soleymanzadeh F; Taylor SJ; Muegge I; Farrow NA; Joseph D; McKellop K; Man CC; Kukulka A; De Lombaert S
J Med Chem; 2009 Oct; 52(19):5880-95. PubMed ID: 19746975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
